Subsequent reduction of insurance prices deteriorating domestic pharmaceutical business

Business observers say that the recent government drug-related polices designed to reduce the insurance-covered drugs have dragged the overall pharmaceutical business into a serious setback, following a series of insurance price reductions: (1) average 2.9 percent drop on 781 items (136 firms) on July 1, and (2) average 9.14 percent dip on 776 items (105 firms) to take effect on August 1.

Th...